Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

1.9K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

868
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
868
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

97
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
97
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Transesophageal Echocardiogram on Clinical Outcomes for Patients with <i>Staphylococcus aureus</i> Bloodstream Infection.

Antibiotics (Basel, Switzerland)·2026
Same author

Priced Out of Treatment: The Exorbitant Cost of Antiparasitic Drugs in the United States.

Open forum infectious diseases·2026
Same author

Implementation and performance of a nurse administered modified PEN-FAST clinical decision rule in the electronic health record.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

Significant Publications on Infectious Diseases Pharmacotherapy in 2023.

Journal of pharmacy practice·2025
Same author

Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics.

Open forum infectious diseases·2021
Same author

Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative.

Open forum infectious diseases·2020

Related Experiment Video

Updated: May 6, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K

Significant Publications on Infectious Diseases Pharmacotherapy in 2024.

Lauren Lee1, Yao-Hsuan Huang2, Hiba Al Shaikhli1

  • 1Department of Pharmacy, The University of Texas Medical Branch, Galveston, TX, USA.

Journal of Pharmacy Practice
|December 11, 2025
PubMed
Summary
This summary is machine-generated.

This review summarizes key 2024 infectious diseases (ID) pharmacotherapy advancements, highlighting practice-changing research in general ID and HIV/AIDS. It aids clinicians in staying updated on the latest ID pharmacotherapy literature.

Keywords:
anti-infectiveantimicrobial stewardshiphuman immunodeficiency virusinfectious diseasespharmacotherapy

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K

Related Experiment Videos

Last Updated: May 6, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K

Area of Science:

  • Pharmacotherapy
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Infectious diseases (ID) pharmacotherapy is a rapidly evolving field.
  • Staying abreast of significant research is crucial for clinical practice.
  • Recent advancements require regular updates for healthcare professionals.

Purpose of the Study:

  • To summarize the most significant infectious diseases pharmacotherapy articles published in 2024.
  • To identify and review practice-changing publications in general ID and HIV/AIDS pharmacotherapy.
  • To provide clinicians with a concise overview of recent ID pharmacotherapy literature.

Main Methods:

  • Nomination of notable articles by the Houston Infectious Diseases Network (HIDN).
  • Survey distributed to Society of Infectious Diseases Pharmacists (SIDP) members for article selection.
  • Summarization of top-voted general ID and HIV/AIDS pharmacotherapy articles from 2024.

Main Results:

  • 19 general ID and 2 HIV/AIDS pharmacotherapy articles were nominated.
  • 185 SIDP members voted for top general ID articles; 46 voted for top HIV/AIDS articles.
  • The most significant publications in ID pharmacotherapy for 2024 are summarized.

Conclusions:

  • This review offers a timely summary of recent ID pharmacotherapy literature.
  • Clinicians can use this information to update their knowledge on potential practice-changing ID pharmacotherapy.
  • The findings highlight key advancements in infectious diseases treatment strategies for 2024.